|
Dr. Anagnostopoulos has served as Chair since 2001. He is Managing General Partner of Gateway Venture Partners, and also serves as Chairman of Metaphore Pharmaceuticals and on the boards of a number of other biotechnology companies, including Dyax and Genzyme. Dr. Anagnostopoulos is a retired officer of Monsanto Company, where he also served as Director of R&D, general manager of a number of operating divisions and Chairman, President and Chief Executive Officer of Monsanto Europe-Africa. As Head of Monsanto�s New Enterprise Division, he was the architect of Monsanto�s pioneering activities in corporate venture capital and served as President and Chief Executive Officer of Monsanto Venture Capital Company. Dr. Anagnostopoulos holds a Ph.D. in Organic Chemistry from Harvard University and over 20 patents in Organic and Polymer Chemistry. | 